US Biotech Companies Increasingly Keep Early Research Confidential
Some US biotech companies and researchers are disclosing less early research data over concerns that competitors could use their findings to bring products to market first. Industry figures cite funding and development pressures, while a study shows the US share of early-stage drug development fell between 2015 and 2024 as China's rose.

